by: Todd Martinsky, Arrayit Corporation
Background: Arrayit patented microarray printing technology (6,101,946) enables the manufacturing of miniaturized arrays (microarrays) of all biomolecule types onto specially treated glass slides, microfluidic devices and other biochip substrates. We make protein microarrays by mechanically “nano” printing antigens into tiny ordered arrays to simultaneously quantify multiple immunoglobulin antibodies across many antigens in human sera. The miniaturization, multiplexing, parallelism and 1, 2 or 4-color platform increases the throughput and sensitivity of immunoassays, while at the same time lowers cost through miniaturization.